The Current Ratio as of November 2024 (TTM) for Bionano Genomics, Inc. (BNGO) is 1.43

According to Bionano Genomics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.43. This represents a change of -3.65% compared to the average of 1.48 of the last 4 quarters.

Bionano Genomics, Inc. (BNGO) Historical Current Ratio (quarterly & annually)

How has BNGO Current Ratio performed in the past?

The mean historical Current Ratio of Bionano Genomics, Inc. over the last ten years is 3.90. The current 1.43 Current Ratio has changed 3.55% with respect to the historical average. Over the past ten years (40 quarters), BNGO's Current Ratio was at its highest in in the March 2021 quarter at 51.65. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Bionano Genomics, Inc. (BNGO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bionano Genomics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bionano Genomics, Inc. (BNGO) Average Current Ratio

How has BNGO Current Ratio performed in the past?

The current Current Ratio of Bionano Genomics, Inc. (BNGO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bionano Genomics, Inc. (BNGO) Current Ratio vs. Peers

How is BNGO’s Current Ratio compared to its peers?

Bionano Genomics, Inc.’s Current Ratio is less than Intuitive Surgical, Inc. (4.30), less than Innovative Eyewear, Inc. (16.83K), greater than Stereotaxis, Inc. (1.39), less than NEXGEL, Inc. (1.51), less than Microbot Medical Inc. (3.64), less than STAAR Surgical Company (5.99), less than Envista Holdings Corporation (2.08), greater than G Medical Innovations Holdings Ltd (0.22), less than Becton, Dickinson and Company (11.11), less than West Pharmaceutical Services, Inc. (3.00), less than ResMed Inc. (2.92), greater than Wearable Health Solutions, Inc. (0.01), greater than BioLife Sciences Inc. (0), greater than Psykey, Inc. (0.24), greater than Predictive Oncology Inc. (1.20), greater than Sharps Technology, Inc. (0.98), greater than GlucoTrack, Inc. (0.14), less than Meihua International Medical Technologies Co., Ltd. (4.78),

Build a custom stock screener for Bionano Genomics, Inc. (BNGO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionano Genomics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bionano Genomics, Inc. (BNGO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bionano Genomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.